Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.

Otieno, Lucas; Guerra Mendoza, Yolanda; Adjei, Samuel; Agbenyega, Tsiri; Agnandji, Selidji Todagbe; Aide, Pedro; Akoo, Pauline; Ansong, Daniel; Asante, Kwaku Poku; Berkley, James A; +27 more... Gesase, Samwel; Hamel, Mary J; Hoffman, Irving; Kaali, Seyram; Kamthunzi, Portia; Kariuki, Simon; Kremsner, Peter; Lanaspa, Miguel; Lell, Bertrand; Lievens, Marc; Lusingu, John; Malabeja, Anangisye; Masoud, Nahya Salim; Mtoro, Ali Takadir; Njuguna, Patricia; Ofori-Anyinam, Opokua; Otieno, Godfrey Allan; Otieno, Walter; Owusu-Agyei, Seth; Schuerman, Lode; Sorgho, Hermann; Tanner, Marcel; Tinto, Halidou; Valea, Innocent; Vandoolaeghe, Pascale; Sacarlal, Jahit; Oneko, Martina; (2019) Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa. Vaccine, 38 (4). pp. 897-906. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2019.10.077

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2019.10.077

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Disease Control
PubMed ID 31708182
Elements ID 141412

Share

Download

Filename: 1-s2.0-S0264410X19314665-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar